Biogen Inc (BIIB)

Index:

Nasdaq 100

$ 158.01
   
  • Change Today:
    $2.01
  • 52 Week High: $267.71
  • 52 Week Low: $154.74
  • Currency: US Dollars
  • Shares Issued: 144.90m
  • Volume: 1,886,119
  • Market Cap: $22,896m
  • RiskGrade: 259

Biogen Inc Overview

In November 2003, Biogen and IDEC Pharmaceuticals finalised their $6bn merger, creating Biogen Idec, the third-largest biotechnology company in the world. The company is now a global leader in the development, manufacturing, and commercialisation of novel therapies. Its major products include treatments for relapsing multiple sclerosis, certain B-cell non-Hodgkin's lymphomas and adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

1 Day Chart (21-11-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 13.2%
ROCE 17.2%
Latest F'cast
P/E 19.7
PEG n/a
Pr/Revenue 2.3
Pr/Book 1.5
Latest F'cast
Revenue -3.3%
PBT -63.9%
EPS -61.7%
DPS n/a

Biogen Inc Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 14,377.90 7,125.90 3,147.00¢ 9.4 0.0 +482% n/a 0.0%
31-Dec-20 13,444.60 5,052.80 2,486.00¢ 9.8 n/a -21% n/a 0.0%
31-Dec-21 10,981.70 1,779.50 1,044.00¢ 23.0 n/a -58% n/a 0.0%
31-Dec-22 10,173.40 3,591.80 2,096.00¢ 13.2 0.1 +101% n/a 0.0%
31-Dec-23 9,835.60 1,296.80 802.00¢ 32.3 n/a -62% n/a 0.0%

Biogen Inc Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 9,640.95 3,039.25 1,642.30¢ 9.6 0.1 +105% n/a 0.0%
31-Dec-25 9,489.50 3,009.36 1,662.46¢ 9.5 7.7 +1% n/a 0.0%
31-Dec-26 9,657.65 3,136.40 1,759.93¢ 9.0 1.5 +6% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Biogen Inc ShareCast News

Biogen ups forecasts despite weak Alzheimer's dr... 20-Oct-2021 ShareCast
Biogen shares soar as FDA approves Alzheimer's d... 08-Jun-2021 ShareCast
Biogen and Sage ink $1.5bn deal to develop anti-... 27-Nov-2020 ShareCast

Biogen Inc Top Newspaper Links

Elan says federal judge ruled it broke terms of ... 04-Sep-2009 Chicago Tribune
Johnson & Johnson Buys Access to an Alzheimer’s ... 03-Jul-2009 New York Times
Icahn Places Two Allies on the Biogen Idec Board 04-Jun-2009 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Biogen Inc Market Data

Currency US Dollars
Share Price $ 158.01
Change Today $ 2.01
% Change 1.29 %
52 Week High $267.71
52 Week Low $154.74
Volume 1,886,119
Shares Issued 144.90m
Market Cap $22,896m
RiskGrade 259

What The Brokers Say

Strong Buy 9
Buy 14
Neutral 13
Sell 0
Strong Sell 0
Total 36
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Nov-2024

Time Volume / Share Price
15:59 300 @ $157.97
15:59 291 @ $157.97
15:59 200 @ $157.91
15:59 211 @ $157.91
15:59 100 @ $157.96

Top of Page